AXGN Axogen Inc.

13.03
-1.28  -9%
Previous Close 14.31
Open 14.23
Price To Book 3.8
Market Cap 514,274,790
Shares 39,468,518
Volume 763,256
Short Ratio
Av. Daily Volume 351,561
Stock charts supplied by TradingView

NewsSee all news

  1. Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance

    ALACHUA, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary

  2. Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestone

    ALACHUA, Fla., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  3. Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetings

    ALACHUA, Fla., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced its

  4. Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference

    ALACHUA, Fla., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  5. Axogen awarded research grant from the Advanced Regenerative Manufacturing Institute

    Company will develop an automated bioprocessing system for human tissue scaffolds ALACHUA, Fla., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 3 enrolment to be completed summer 2020.
Avance Nerve Graf
Severed peripheral nerves

Latest News

  1. Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance

    ALACHUA, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary

  2. Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestone

    ALACHUA, Fla., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  3. Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetings

    ALACHUA, Fla., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced its

  4. Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference

    ALACHUA, Fla., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  5. Axogen awarded research grant from the Advanced Regenerative Manufacturing Institute

    Company will develop an automated bioprocessing system for human tissue scaffolds ALACHUA, Fla., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative

  6. Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float

    ALACHUA, Fla., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  7. Axogen, Inc. to Participate at Piper Jaffray 31st Annual Healthcare Conference

    ALACHUA, Fla., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  8. Axogen, Inc. to Participate at Jefferies London Healthcare Conference

    ALACHUA, Fla., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced

  9. Axogen, Inc. Reports 2019 Third Quarter Financial Results

    ALACHUA, Fla., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today reported

  10. Scott+Scott Attorneys at Law LLP Investigating Axogen, Inc.'s Directors and Officers for Breach of Fiduciary Duties - AXGN

    NEW YORK, Oct. 3, 2019 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of

  11. Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference

    ALACHUA, Fla., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced